After mentoring IndieBio life science startups since 2018, in 2020 Stephen joined SOSV full-time to co-found IndieBio NY. Stephen heads the IndieBio NY program, has a PhD in Molecular Biology, and has a deep background in entrepreneurship in the pharma industry.
Stephen was one of the founding scientists at Vertex Pharmaceuticals, working on many drug discovery programs including in the FDA approval of Agenerase & Lexiva. He went on to co-found Abpro Therapeutics, employing synthetic biology and immunology to accelerate antibody discovery and development.
